Indeed, while enhanced GLP-1R signaling outside of the islet may mediate, at least in part, the in vivo effects of GLP-1R agonists on enhanced islet function, studies performed in isolated islets, in the absence of peripheral GLP-1R signaling, confirm the propensity for GLP-1R agonists to induce direct intra-islet effects ( Figure 4 )
For an overweight man with borderline fertility or ED, starting a GLP-1 RA and losing significant weight might be one of the best things he can do it addresses the root causes (obesity, insulin resistance) that underlie many cases of male subfertility and ED
10.1038/nature09782 32 LiW.ZhaoS.ChengF.RaoT.YuW.RuanY.et al (2018)
The FDA has approved oral semaglutide for adults with obesity (BMI 30) or overweight adults (BMI 27) who also have at least one weight-related condition, such as: Type 2 diabetes High blood pressure Dyslipidemia Cardiovascular disease risk Dr
A prospective multicentre trial
Now used for medical weight loss, Semaglutide GLP-1 injections are very popular